Found 32 Breast Cancer trials
A listing of Breast Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Sort by:
Featured study
The purpose of this research study is to learn about using traditional Chinese medicine (TCM) along with usual Western medical treatment for women with primary breast cancer. The study focuses on side effects that can happen during cancer treatment, such as low blood cell counts, nausea, vomiting, stomach or bowel …
The current study aims to provide validation results of RNA Disruption Assay (RDA) as a tumour response assessment tool that uses tumour core biopsies taken starting from 35 +/- 4 days after the initiation of neoadjuvant chemotherapy.
This phase II trial studies how well radiation therapy with or without olaparib works in treating patients with inflammatory breast cancer.
This randomized phase III trial studies how well pembrolizumab works in treating patients with triple-negative breast cancer.
The study will compare cases of DCIS that either did or did not recur as invasive cancer.
The purpose of this research study is to determine how well neratinib, by itself or together with Fulvestrant, works in treating breast cancer that has spread to other parts of the body. We will also be looking at the side effects associated with this combination of drugs.
The purpose of this study is to see if telephone support programs help patients adjust to metastatic breast cancer.
The purpose of this study is to find out how often cancer is identified by excisional biopsy near an initial core biopsy where FEA or IPWA has previously been seen.
The purpose of this study is to collect inflammatory breast cancer specimens. Researchers will look at differences between specimens. They will study the disease development with the goal of improving ways to prevent, diagnose and treat inflammatory breast cancer.
The purpose of this study is to test how well the combination of study drugs, carboplatin and atezolizumab, keeps metastatic triple negative breast cancer from growing compared to taking carboplatin only.
Please choose between Voice or SMS based delivery of verification code
or